Attached files
file | filename |
---|---|
EX-10.1 - CONSULTING AGREEMENT - ANAVEX LIFE SCIENCES CORP. | exhibit10-1.htm |
EX-99.1 - NEWS RELEASE DATED APRIL 8, 2011 - ANAVEX LIFE SCIENCES CORP. | exhibit99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported) March 30,
2011
ANAVEX LIFE SCIENCES
CORP.
(Exact name of registrant as specified in its
charter)
Nevada | 000-51652 | 20-8365999 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
50 Harrison Street, Suite 315A, Hoboken, New Jersey
07030
(Address of principal executive offices and Zip
Code)
Registrant's telephone number, including area code
1-800-689-3939
N/A
(Former name or former
address, if changed since last report)
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:
[
] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[
] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
2
Item 1.01 | Entry into a Material Definitive Agreement |
On March 30, 2011 we entered into a consulting agreement with Shackleton Consulting Corp., a company incorporated in the province of British Columbia, pursuant to which Shackleton will act as our advisor in identifying business opportunities and strategic development. As consideration for acting as our advisor, we agreed to:
(a) |
pay US $500 per hour up to a maximum of five hours per month; | |
(b) |
reimburse pre-approved expenses and certain travel expenses as approved by our company; and | |
(c) |
issue 100,000 share purchase options at a price of US $3.67 per option share for a period of five years. |
The securities are being issued to one non-U.S. person (as that term is defined in Regulation S of the Securities Act of 1933, as amended) in an offshore transaction in which we relied on the registration exemption provided for in Regulation S and/or Section 4(2) of the Securities Act of 1933, as amended.
The consulting agreement is for a period of one year, unless extended, and may be terminated by either party with one months written notice.
A copy of the consulting agreement is attached as exhibit 10.1 to this current report on Form 8-K.
Item 3.02 | Unregistered Sales of Equity Securities. |
The information provided under Item 1.01 is responsive to the information required by this Item 3.02 and is hereby incorporated by reference.
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits |
10.1 | Consulting Agreement dated March 30, 2011 with Shackleton Consulting Corp. |
99.1 | News release dated April 8, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ANAVEX LIFE SCIENCES CORP.
/s/ Harvey Lalach
Harvey Lalach
President,
Chief Operating Officer and Director
Date: April 12, 2011